The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Neuromuscular Blockade

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Neuromuscular Blockade


Psychiatry related information on Neuromuscular Blockade


High impact information on Neuromuscular Blockade


Chemical compound and disease context of Neuromuscular Blockade


Biological context of Neuromuscular Blockade


Anatomical context of Neuromuscular Blockade


Associations of Neuromuscular Blockade with chemical compounds


Gene context of Neuromuscular Blockade


Analytical, diagnostic and therapeutic context of Neuromuscular Blockade


  1. Persistent paralysis in critically ill patients after long-term administration of vecuronium. Segredo, V., Caldwell, J.E., Matthay, M.A., Sharma, M.L., Gruenke, L.D., Miller, R.D. N. Engl. J. Med. (1992) [Pubmed]
  2. Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors. Kaur, J., Zhang, M.Q. Current medicinal chemistry. (2000) [Pubmed]
  3. Paralysis in the critically ill: intermittent bolus pancuronium compared with continuous infusion. de Lemos, J.M., Carr, R.R., Shalansky, K.F., Bevan, D.R., Ronco, J.J. Crit. Care Med. (1999) [Pubmed]
  4. Mild intraoperative hypothermia increases duration of action and spontaneous recovery of vecuronium blockade during nitrous oxide-isoflurane anesthesia in humans. Heier, T., Caldwell, J.E., Sessler, D.I., Miller, R.D. Anesthesiology (1991) [Pubmed]
  5. Onset and duration of rocuronium-induced neuromuscular blockade in patients with Duchenne muscular dystrophy. Wick, S., Muenster, T., Schmidt, J., Forst, J., Schmitt, H.J. Anesthesiology (2005) [Pubmed]
  6. The comparative effects of remifentanil or magnesium sulfate versus placebo on attenuating the hemodynamic responses after electroconvulsive therapy. van Zijl, D.H., Gordon, P.C., James, M.F. Anesth. Analg. (2005) [Pubmed]
  7. Train-of-four fade during neuromuscular blockade induced by tubocurarine, succinylcholine or alpha-bungarotoxin in the rat isolated hemidiaphragm. Cheah, L.S., Gwee, M.C. Clin. Exp. Pharmacol. Physiol. (1988) [Pubmed]
  8. Amantadine: neuromuscular blockade by suppression of ionic conductance of the acetylcholine receptor. Albuquerque, E.X., Eldefrawi, A.T., Eldefrawi, M.E., Mansour, N.A., Tsai, M.C. Science (1978) [Pubmed]
  9. Effective treatment of verapamil intoxication with 4-aminopyridine in the cat. Agoston, S., Maestrone, E., van Hezik, E.J., Ket, J.M., Houwertjes, M.C., Uges, D.R. J. Clin. Invest. (1984) [Pubmed]
  10. Role of the diaphragm in the genesis of lower esophageal sphincter pressure in the cat. Boyle, J.T., Altschuler, S.M., Nixon, T.E., Tuchman, D.N., Pack, A.I., Cohen, S. Gastroenterology (1985) [Pubmed]
  11. Procainamide-induced myasthenia-like weakness in a patient with peripheral neuropathy. Niakan, E., Bertorini, T.E., Acchiardo, S.R., Werner, M.F. Arch. Neurol. (1981) [Pubmed]
  12. Dose response, recovery, and cost of doxacurium as a continuous infusion in neurosurgical intensive care unit patients. Prielipp, R.C., Robinson, J.C., Wilson, J.A., MacGregor, D.A., Scuderi, P.E. Crit. Care Med. (1997) [Pubmed]
  13. Practice parameters for sustained neuromuscular blockade in the adult critically ill patient: an executive summary. Society of Critical Care Medicine. Shapiro, B.A., Warren, J., Egol, A.B., Greenbaum, D.M., Jacobi, J., Nasraway, S.A., Schein, R.M., Spevetz, A., Stone, J.R. Crit. Care Med. (1995) [Pubmed]
  14. The effects of antagonizing residual neuromuscular blockade by neostigmine and glycopyrrolate on nausea and vomiting after ambulatory surgery. Joshi, G.P., Garg, S.A., Hailey, A., Yu, S.Y. Anesth. Analg. (1999) [Pubmed]
  15. Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants. Tempelhoff, R., Modica, P.A., Jellish, W.S., Spitznagel, E.L. Anesth. Analg. (1990) [Pubmed]
  16. Pharmacokinetics and pharmacodynamics of atracurium obtained with arterial and venous blood samples. Donati, F., Varin, F., Ducharme, J., Gill, S.S., Théorêt, Y., Bevan, D.R. Clin. Pharmacol. Ther. (1991) [Pubmed]
  17. Neuromuscular transmission in neonatal mice injected with serum globulin of myasthenia gravis patients. Pagala, M.K., Tada, S., Namba, T., Grob, D. Neurology (1982) [Pubmed]
  18. Effects of partial neuromuscular blockade on carotid baroreflex function during exercise in humans. Gallagher, K.M., Fadel, P.J., Strømstad, M., Ide, K., Smith, S.A., Querry, R.G., Raven, P.B., Secher, N.H. J. Physiol. (Lond.) (2001) [Pubmed]
  19. The effect of H2-receptor antagonist premedication on the duration of vecuronium-induced neuromuscular blockade in postpartum patients. Hawkins, J.L., Adenwala, J., Camp, C., Joyce, T.H. Anesthesiology (1989) [Pubmed]
  20. Pharmacokinetics of edrophonium and neostigmine when antagonizing d-tubocurarine neuromuscular blockade in man. Morris, R.B., Cronnelly, R., Miller, R.D., Stanski, D.R., Fahey, M.R. Anesthesiology (1981) [Pubmed]
  21. Methodologic aspects of a population pharmacodynamic model for cognitive effects in Alzheimer patients treated with tacrine. Holford, N.H., Peace, K.E. Proc. Natl. Acad. Sci. U.S.A. (1992) [Pubmed]
  22. Curare-induced transformation of myosin pattern in developing skeletal muscle fibers. Gauthier, G.F., Ono, R.D., Hobbs, A.W. Dev. Biol. (1984) [Pubmed]
  23. Partial neuromuscular blockade and cardiovascular responses to static exercise in man. Leonard, B., Mitchell, J.H., Mizuno, M., Rube, N., Saltin, B., Secher, N.H. J. Physiol. (Lond.) (1985) [Pubmed]
  24. Adverse effects of depolarising neuromuscular blocking agents. Incidence, prevention and management. Book, W.J., Abel, M., Eisenkraft, J.B. Drug safety : an international journal of medical toxicology and drug experience. (1994) [Pubmed]
  25. Mn(2+) ions reduce the enzymatic and pharmacological activities of bothropstoxin-I, a myotoxic Lys49 phospholipase A(2) homologue from Bothrops jararacussu snake venom. Soares, A.M., Oshima-Franco, Y., Vieira, C.A., Leite, G.B., Fletcher, J.E., Jiang, M.S., Cintra, A.C., Giglio, J.R., Rodrigues-Simioni, L. Int. J. Biochem. Cell Biol. (2002) [Pubmed]
  26. A new method for excitation-contraction uncoupling in frog skeletal muscle. del Castillo, J., Escalona de Motta, G. J. Cell Biol. (1978) [Pubmed]
  27. Letter: Gentamicin and neuromuscular blockade. Holtzman, J.L. Ann. Intern. Med. (1976) [Pubmed]
  28. The neurotoxicity of antibacterial agents. Snavely, S.R., Hodges, G.R. Ann. Intern. Med. (1984) [Pubmed]
  29. Clinical significance of the interaction between lithium and a neuromuscular blocker. Martin, B.A., Kramer, P.M. The American journal of psychiatry. (1982) [Pubmed]
  30. Pharmacokinetic analysis of the time course of effect of atracurium. Warwick, N.R., Graham, G.G., Torda, T.A. Clin. Pharmacol. Ther. (1995) [Pubmed]
  31. Analysis of mutations in the plasma cholinesterase gene of patients with a history of prolonged neuromuscular block during anesthesia. Barta, C., Sasvari-Szekely, M., Devai, A., Kovacs, E., Staub, M., Enyedi, P. Mol. Genet. Metab. (2001) [Pubmed]
  32. Electrical myotonia and cataract in X-linked muscular dystrophy (mdx) mouse. Kurihara, T., Kishi, M., Saito, N., Komoto, M., Hidaka, T., Kinoshita, M. J. Neurol. Sci. (1990) [Pubmed]
  33. Inhibition of neuromuscular transmission in isolated mouse phrenic nerve-diaphragm by the enterotoxin of Clostridium perfringens type A. Sugimoto, N., Miyamoto, A., Horiguchi, Y., Okabe, T., Matsuda, M. Toxicon (1992) [Pubmed]
  34. Susceptibility to upper airway obstruction during partial neuromuscular block. D'Honneur, G., Lofaso, F., Drummond, G.B., Rimaniol, J.M., Aubineau, J.V., Harf, A., Duvaldestin, P. Anesthesiology (1998) [Pubmed]
  35. Population pharmacodynamics of doxacurium. Schmith, V.D., Fiedler-Kelly, J., Abou-Donia, M., Huffman, C.S., Grasela, T.H. Clin. Pharmacol. Ther. (1992) [Pubmed]
  36. Resistance to metocurine-induced neuromuscular blockade in patients receiving phenytoin. Ornstein, E., Matteo, R.S., Young, W.L., Diaz, J. Anesthesiology (1985) [Pubmed]
  37. Pharmacokinetic analysis of the effect of vecuronium in surgical patients: pharmacokinetic and pharmacodynamic modeling without plasma concentrations. Warwick, N.R., Graham, G.G., Torda, T.A. Anesthesiology (1998) [Pubmed]
  38. Edrophonium antagonizes combined lidocaine-pancuronium and verapamil-pancuronium neuromuscular blockade in cats. Carpenter, R.L., Mulroy, M.F. Anesthesiology (1986) [Pubmed]
  39. Vecuronium neuromuscular blockade reflects liver function during hepatic autotransplantation in pigs. Pittet, J.F., Morel, D.R., Mentha, G., Schopfer, C., Belenger, J., Benakis, A., Tassonyi, E. Anesthesiology (1994) [Pubmed]
WikiGenes - Universities